PZ-2891 is primarily utilized in the field of medicinal chemistry as a potential therapeutic agent. It has shown promise in preclinical studies for its ability to modulate specific biological pathways, making it a candidate for treating certain types of diseases, particularly those involving inflammation or metabolic disorders. Researchers are exploring its efficacy in inhibiting key enzymes or receptors that play a role in disease progression. Additionally, PZ-2891 is being investigated for its potential use in combination therapies to enhance the effectiveness of existing treatments. Its application extends to drug development, where it serves as a lead compound for optimizing pharmacokinetic and pharmacodynamic properties. Further studies are ongoing to evaluate its safety and efficacy in clinical settings.